CREKA-lipo-anti-IFNγ combined with cisplatin reduced tumour volume compared with those reduced by cisplatin alone, while lactate abrogated the effect of CREKA-lipo-anti-IFNγ (Figure 6D). Here, IFNG is linked to neoplasm.